These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 38568619)
1. Drug Distribution After Intravitreal Injection: A Mathematical Model. Ruffini A; Casalucci A; Cara C; Ethier CR; Repetto R Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):9. PubMed ID: 38568619 [TBL] [Abstract][Full Text] [Related]
2. [Structural changes in the ocular anterior segment against elevation of intraocular pressure after repeated intravitreal injections]. Budzinskaya MV; Bubnova IA; Kurguzova AG; Fettser EI Vestn Oftalmol; 2018; 134(5. Vyp. 2):156-161. PubMed ID: 30499511 [TBL] [Abstract][Full Text] [Related]
3. Short-term impact of intravitreal ranibizumab injection on axial ocular dimension and intraocular pressure. Goktas A; Goktas S; Atas M; Demircan S; Yurtsever Y Cutan Ocul Toxicol; 2013 Mar; 32(1):23-6. PubMed ID: 22737998 [TBL] [Abstract][Full Text] [Related]
4. The effect of baseline intraocular pressure and anterior segment parameters on intraocular pressure after intravitreal bevacizumab injection. Özer Özcan Z; Gürbostan Soysal G; Tıskaoğlu NS; Berhuni M Cutan Ocul Toxicol; 2023 Dec; 42(4):248-252. PubMed ID: 37531133 [TBL] [Abstract][Full Text] [Related]
5. [Changes in intraocular pressure after intravitreal injections]. Bubnova IA; Kurguzova AG Vestn Oftalmol; 2018; 134(4):47-51. PubMed ID: 30166510 [TBL] [Abstract][Full Text] [Related]
6. Monitoring intraocular pressure changes after intravitreal Ranibizumab injection using rebound tonometry. Fuest M; Kotliar K; Walter P; Plange N Ophthalmic Physiol Opt; 2014 Jul; 34(4):438-44. PubMed ID: 24731161 [TBL] [Abstract][Full Text] [Related]
7. Effect of prophylactic medication and influence of vitreous reflux in pressure rise after intravitreal injections of anti-VEGF drugs. Carnota-Méndez P; Méndez-Vázquez C; Otero-Villar J; Saavedra-Pazos JA Eur J Ophthalmol; 2014; 24(5):771-7. PubMed ID: 24706353 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Anti-Vascular Endothelial Growth Factor Agents on Intraocular Pressure and Glaucoma: A Report by the American Academy of Ophthalmology. Hoguet A; Chen PP; Junk AK; Mruthyunjaya P; Nouri-Mahdavi K; Radhakrishnan S; Takusagawa HL; Chen TC Ophthalmology; 2019 Apr; 126(4):611-622. PubMed ID: 30472176 [TBL] [Abstract][Full Text] [Related]
9. Computational modeling of drug distribution in the posterior segment of the eye: effects of device variables and positions. Jooybar E; Abdekhodaie MJ; Farhadi F; Cheng YL Math Biosci; 2014 Sep; 255():11-20. PubMed ID: 24946303 [TBL] [Abstract][Full Text] [Related]
10. Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases. Jonas JB Acta Ophthalmol Scand; 2005 Dec; 83(6):645-63. PubMed ID: 16396641 [TBL] [Abstract][Full Text] [Related]
11. Effect of intraocular pressure (IOP) and choroidal circulation on controlled episcleral drug delivery to retina/vitreous. Li J; Lan B; Li X; Sun S; Lu P; Cheng L J Control Release; 2016 Dec; 243():78-85. PubMed ID: 27717742 [TBL] [Abstract][Full Text] [Related]
12. Poly(ortho ester) nanoparticles targeted for chronic intraocular diseases: ocular safety and localization after intravitreal injection. Li H; Palamoor M; Jablonski MM Nanotoxicology; 2016 Oct; 10(8):1152-9. PubMed ID: 27108911 [TBL] [Abstract][Full Text] [Related]
13. Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections. Frenkel MP; Haji SA; Frenkel RE Arch Ophthalmol; 2010 Dec; 128(12):1523-7. PubMed ID: 21149773 [TBL] [Abstract][Full Text] [Related]
14. Effect of intravitreal injections and volume changes on intraocular pressure: clinical results and biomechanical model. Kotliar K; Maier M; Bauer S; Feucht N; Lohmann C; Lanzl I Acta Ophthalmol Scand; 2007 Nov; 85(7):777-81. PubMed ID: 17573861 [TBL] [Abstract][Full Text] [Related]
15. Intraocular Pressure Changes Following Intravitreal Melphalan and Topotecan for the Treatment of Retinoblastoma With Vitreous Seeding. Karl MD; Francis JH; Iyer S; Marr B; Abramson DH J Pediatr Ophthalmol Strabismus; 2017 May; 54(3):185-190. PubMed ID: 28092395 [TBL] [Abstract][Full Text] [Related]
16. Intraocular pressure after intravitreal injection of triamcinolone acetonide. Jonas JB; Kreissig I; Degenring R Br J Ophthalmol; 2003 Jan; 87(1):24-7. PubMed ID: 12488256 [TBL] [Abstract][Full Text] [Related]
17. Exogenous vasopressin influences intraocular pressure via the V(1) receptors. Gondim EL; Liu JH; Costa VP; Weinreb RN Curr Eye Res; 2001 Apr; 22(4):295-303. PubMed ID: 11462169 [TBL] [Abstract][Full Text] [Related]
18. Three-Dimensional Transport Model for Intravitreal and Suprachoroidal Drug Injection. Zhang Y; Bazzazi H; Lima E Silva R; Pandey NB; Green JJ; Campochiaro PA; Popel AS Invest Ophthalmol Vis Sci; 2018 Oct; 59(12):5266-5276. PubMed ID: 30383198 [TBL] [Abstract][Full Text] [Related]
19. Current intravitreal therapy and ocular hypertension: A review. Sudhalkar A; Bilgic A; Vasavada S; Kodjikian L; Mathis T; de Ribot FM; Papakostas T; Vasavada V; Vasavada V; Srivastava S; Bhojwani D; Ghia P; Sudhalkar A Indian J Ophthalmol; 2021 Feb; 69(2):236-243. PubMed ID: 33463565 [TBL] [Abstract][Full Text] [Related]
20. A lack of delayed intraocular pressure elevation in patients treated with intravitreal injection of bevacizumab and ranibizumab. Wehrli SJ; Tawse K; Levin MH; Zaidi A; Pistilli M; Brucker AJ Retina; 2012 Jul; 32(7):1295-301. PubMed ID: 22466465 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]